OLFM4 promotes the progression of intestinal metaplasia through activation of the MYH9/GSK3β/β-catenin pathway
Molecular Cancer · 07.06.2024 · 23 (1)
DOI: 10.1186/s12943-024-02016-9 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular Cancer, online erschienen am 07.06.2024. Verfasst von Hongfa Wei und 17 weiteren Autor:innen. Beteiligte Einrichtung: Department of General Surgery, The First Affiliated Hospital of Shantou University Medical College, Jinping, Shantou, Guangdong, 515041, P.R. China. Hauptthemen laut MEDLINE: Metaplasia, Glycogen Synthase Kinase 3 beta, beta Catenin, Myosin Heavy Chains. Die Arbeit wurde bisher 45-mal zitiert (Crossref) und nennt 76 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Guangdong Provincial Key Laboratory of Digestive Cancer Research, Guangdong Basic and Applied Basic Research Foundation, the Science and Technology Planning Project of Shenzhen Municipality.
Abstract (Originalsprache)
Background
Intestinal metaplasia (IM) is classified into complete intestinal metaplasia (CIM) and incomplete intestinal metaplasia (IIM). Patients diagnosed with IIM face an elevated susceptibility to the development of gastric cancer, underscoring the critical need for early screening measures. In addition to the complexities associated with diagnosis, the exact mechanisms driving the progression of gastric cancer in IIM patients remain poorly understood. OLFM4 is overexpressed in several types of tumors, including colorectal, gastric, pancreatic, and ovarian cancers, and its expression has been associated with tumor progression.
Methods
In this study, we used pathological sections from two clinical centers, biopsies of IM tissues, precancerous lesions of gastric cancer (PLGC) cell models, animal models, and organoids to explore the role of OLFM4 in IIM.
Results
Our results show that OLFM4 expression is highly increased in IIM, with superior diagnostic accuracy of IIM when compared to CDX2 and MUC2. OLFM4, along with MYH9, was overexpressed in IM organoids and PLGC animal models. Furthermore, OLFM4, in combination with Myosin heavy chain 9 (MYH9), accelerated the ubiquitination of GSK3β and resulted in increased β-catenin levels through the Wnt signaling pathway, promoting the proliferation and invasion abilities of PLGC cells.
Conclusions
OLFM4 represents a novel biomarker for IIM and could be utilized as an important auxiliary means to delimit the key population for early gastric cancer screening. Finally, our study identifies cell signaling pathways involved in the progression of IM.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of General Surgery, The First Affiliated Hospital of Shantou University Medical College, Jinping, Shantou, Guangdong, 515041, P.R. China.
- Department of Gastrointestinal Surgery, Digestive Diseases Center, The Seventh Affiliated Hospital, Sun Yat-Sen University, Shenzhen, 518107, China.
- The Department of Thyroid and Breast Surgery, The Third Affiliated Hospital of Sun Yat-Sen University, Guangzhou, China.
- Scientific Research Center, The Biobank, The Seventh Affiliated Hospital of Sun Yat-Sen University, Shenzhen, 518107, Guangdong, P.R. China.
- Department of Laboratory Medicine, Shenzhen People's Hospital, (The Second Clinical Medical College, Jinan University, The First Affiliated Hospital, Southern University of Science and Technology), Shenzhen, Guangdong,…
- Department of General Surgery, The First Affiliated Hospital of Shantou University Medical College, Jinping, Shantou, Guangdong, 515041, P.R. China. feiran.z@126.com.
Förderung
- Guangdong Provincial Key Laboratory of Digestive Cancer Research
- Guangdong Basic and Applied Basic Research Foundation
- the Science and Technology Planning Project of Shenzhen Municipality
- He Yulong Expert Workstation of Yunnan Province
- Science and Technology Special Project of the National Sustainable Development Agenda Innovation Demonstration Zone of Yunnan Province
- the National Natural Science Foundation of China
Zitieren
APA
Wei, H., Li, W., Zeng, L., Ding, N., Li, K., Yu, H., Jiang, F., Yin, H., Xia, Y., Deng, C., Cai, N., Chen, X., Gu, L., Chen, H., Zhang, F., He, Y., Li, J., & Zhang, C. (2024). OLFM4 promotes the progression of intestinal metaplasia through activation of the MYH9/GSK3β/β-catenin pathway. Molecular Cancer, 23(1). https://doi.org/10.1186/s12943-024-02016-9
Vancouver
Wei H, Li W, Zeng L, Ding N, Li K, Yu H, et al. OLFM4 promotes the progression of intestinal metaplasia through activation of the MYH9/GSK3β/β-catenin pathway. Molecular Cancer. 2024;23(1). doi:10.1186/s12943-024-02016-9
BibTeX
@article{Wei2024,
author = {Wei, Hongfa and Li, Wenchao and Zeng, Leli and Ding, Ni and Li, Kuan and Yu, Hong and Jiang, Fei and Yin, Haofan and Xia, Yu and Deng, Cuncan and Cai, Nan and Chen, Xiancong and Gu, Liang and Chen, Huanjie and Zhang, Feiran and He, Yulong and Li, Jia and Zhang, Changhua},
title = {OLFM4 promotes the progression of intestinal metaplasia through activation of the MYH9/GSK3β/β-catenin pathway},
journal = {Molecular Cancer},
year = {2024},
volume = {23},
number = {1},
doi = {10.1186/s12943-024-02016-9}
}
EUVIMED